# ALAN AMC

> ALAN AMC is a VC fund in Beijing backing Medical, Health Care and Manufacturing. See 15 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 15
- Last investment: Jul 2026
- Lead investor: 20%
- Last updated: Aug 2026
- Website: http://www.alanamc.com

ALAN AMC is an asset management firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 6 | 40% |
| Health Care | 4 | 27% |
| Manufacturing | 4 | 27% |
| Biotechnology | 3 | 20% |
| Pharmaceutical | 3 | 20% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 40% |
| Series B | 5 | 33% |
| Series C | 1 | 7% |
| Series D | 1 | 7% |
| Venture - Series Unknown | 1 | 7% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GOWIN Semiconductor | Founded in 2014, GOWIN Semiconductor Corp., headquartered with major R&D in China, has the vision to accelerate customer innovation world wide with their programmable solutions. They focus on optimizing their products and removing barriers for customers using programmable logic devices. Their commitment to technology and quality enablescustomers to reduce the total cost of ownership from using FPGA on their production boards. Their offerings include a broad portfolio of programmable logic devices, design software, intellectual property (IP) cores, reference designs, and development kits. They strive to serve customers in the consumer, industrial, communication, medical, and automotive markets worldwide. |  | Venture - Series Unknown | Jul 02, 2026 |  |
| Xinhui Equipment | Xinhui Equipment is a high-tech enterprise integrating R&D, production and sales of semiconductor-specific equipment. The company is committed to the localization of semiconductor equipment and core components. |  | Series B | Feb 14, 2026 |  |
| Jingyuyimei | Jingyuyimei develops medical aesthetic materials and several new material subcutaneous injection filler products. |  | Series A | Jun 18, 2024 |  |
| Monyan Pharma | Monyan Pharma is a pharmaceutical company that specializes in manufacturing natural and chemical medicines and health foods for oncotherapy. | $13.7M | Series B | Nov 13, 2023 |  |
| Baiying Bio | Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression inmammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers. | $72.6M | Series B | Aug 31, 2022 |  |
| Biointron | Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China. | $72.6M | Series B | Aug 31, 2022 |  |
| Junsai Shengwu | Junsai Shengwu developes therapies for new solid tumor cell. | $23.6M | Series A | Jan 15, 2022 |  |
| Juncell Therapeutics | Juncell Therapeutics develops innovative therapies and pharmaceutical drugs for tumor and related treatment. |  | Series A | Jan 15, 2022 |  |
| SVOLT | SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energyvehicle charging piles, batteries recycling, and solutions. |  | Series A | Mar 22, 2021 |  |
| SVOLT | SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energyvehicle charging piles, batteries recycling, and solutions. | $540.2M | Series A | Feb 26, 2021 |  |

10 of 15 investments shown.

## Co-investors
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [Binfu Capital](https://shizune.co/investors/profile/binfu-capital) — VC Fund, 2 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together
- [BOC Capital](https://shizune.co/investors/profile/boc-capital) — VC Fund, 2 deals together
- [Cathay Capital](https://shizune.co/investors/profile/cathaycapital) — VC Fund, 2 deals together
- [Co-Stone Venture Capital](https://shizune.co/investors/profile/co-stone-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does ALAN AMC invest in?

ALAN AMC invests primarily in Medical, Health Care and Manufacturing startups, most often at Series A and Series B stage. Most of the 15 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ALAN AMC last invest?

The most recent investment recorded for ALAN AMC closed in Jul 2026. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co